In the final part of this 5-part series, panelists discuss new allergy treatments such as Xolair, early immunotherapy, and their broader impact.
Colleen Kraft, MD, MBA
Advertisement
Colleen Kraft, MD, is a clinical professor of Pediatrics at the Keck School of Medicine of USC and an attending physician at the Children’s Hospital Los Angeles.
Articles by Colleen Kraft, MD, MBA
In part 4 of this 5-part series, panelists discuss gaps in pediatric food allergy care, stressing better diagnosis, education, and management.
In part 3 of this 5-part series, panelists discuss the recent Neffy approval, oral immunotherapy, and Xolair’s role in allergy management.
In part 2 of this 5-part series, panelists discuss confusion in food allergy diagnosis and the need for better medical education.
In part 1 of this 5-part series, panelists discuss early allergen introduction, oral immunotherapy, and Xolair for food allergy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Tapinarof cream, 1% (VTAMA) shows early improvements in pediatric atopic dermatitis
2
Genetic testing reveals key CNVs in affected children
3
Neurodevelopmental disorder risks not increased by prenatal acetaminophen use
4
Valeria Cohran, MD, highlights specialist-pediatrician collaboration when treating short bowel syndrome-associated intestinal failure
5
